Yatharth Hospital & Trauma Care Services Ltd

  • BSE Code : 543950
  • NSE Symbol : YATHARTH
  • ISIN : INE0JO301016
  • Industry :HEALTHCARE

up-arrow 768.75 19.10(2.55%)

Open Price ()

758.70

Prev. Close ()

749.65

Volume (No’s)

1,414,442

Market Cap ()

7,407.24

Low Price ()

751.50

High Price ()

789.00

 

Board Meetings

Start Date End Date Purpose
31-Jul-2025 05-Aug-2025 Yatharth Hospital & Trauma Care Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2025 inter alia to consider and approve Unaudited Financial Results for the first quarter ended June 30 2025. We hereby submit Outcome of the Board Meeting (As per BSE Announcement Dated on 05/08/2025)
17-Jul-2025 17-Jul-2025 We hereby inform that the Company has shifted its Corporate Office
19-May-2025 26-May-2025 Yatharth Hospital & Trauma Care Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve We hereby submit intimation of the Board Meeting is scheduled to be held on Monday May 26 2025. We hereby submit Audited Financial Results for the Q4 & FY25 (As Per BSE Announcement Dated on 26.05.2025)
21-Jan-2025 27-Jan-2025 Yatharth Hospital & Trauma Care Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 inter alia to consider and approve To consider and approve the financial results of the company for the quarter ended December 31 2024. Quarterly Financial Result for Q3FY25 (As Per BSE Announcement Dated on: 27/01/2025)
01-Nov-2024 07-Nov-2024 Yatharth Hospital & Trauma Care Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2024 inter alia to consider and approve 1- the Unaudited Financial Results (Standalone and Consolidated) with limited review report of the Company for the quarter and half year ended September 30 2024. 2- to raising of funds by way of inter alia issue of equity shares or any other equity linked instruments or securities including convertible preference shares and warrants entitling the warrant holder(s) to apply for equity shares or any other eligible securities through inter alia a private placement (including one or more qualified institutions placements) or further public issue of equity preferential issue or through any other permissible mode under applicable laws and/ or combination thereof as may be considered appropriate subject to such statutory/regulatory/other approvals as may be required. 3- The Board if required would further consider obtaining the approval of shareholders for the above proposals if the same are approved by the Board. Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (As Per BSE Announcement dated on 07.11.2024)

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew